OASA PHARADR Chart calendar OASA PHARADR
1c02174af5d3dc0fdce043b0.NyH1XnPor0b6OQYr0bcNkEw1L1XpfUQdF-XhcvKq3zw.bRe5GwOE4yOjAEcatcdU-CV7ewObLTF2coijIYL1umNfTccSFKTID8hjaQ~7d0a48ddd441a359d321af5851f5d23a
Upcoming events on OASA PHARADR
Past events on OASA PHARADR
| 21/02/2024 | Q4 2023 Earnings Release |
| 15/11/2023 | Q3 2023 Earnings Release |
| 23/08/2023 | Q2 2023 Earnings Release |
| 25/05/2023 08:00 | Annual General Meeting |
| 25/05/2023 07:00 | Q1 2023 Earnings Release |
| 23/02/2023 07:00 | FY 2022 Earnings Release |
| 17/11/2022 09:00 | Q3 2022 Earnings Call |
| 17/11/2022 07:00 | Q3 2022 Earnings Release |
| 25/08/2022 09:00 | Interim 2022 Earnings Call |
| 25/08/2022 07:00 | Interim 2022 Earnings Release |
| 25/05/2022 09:00 | Q1 2022 Earnings Call |
| 25/05/2022 07:00 | Q1 2022 Earnings Release |
| 24/05/2022 | Annual General Meeting |
| 03/05/2022 | Anglonordic Life Science Conference |
| 22/03/2022 | Vator Swiss Nordic BIO |
| 13/03/2022 | Investor Meeting |
| 28/02/2022 | Sachs Associates European Life Sciences CEO Forum |
| 24/02/2022 09:00 | FY 2021 Earnings Call |
| 24/02/2022 07:00 | FY 2021 Earnings Release |
| 21/02/2022 09:00 | Extraordinary Shareholders Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 1,98 12,1 -83.64% | 0,00 | 26,2 16,5 58.74% | 1,02 2,00 -49.25% |
|
EBITDA Million SEK | Released Forecast Spread | -114 -88,4 -28.41% | 0,00 | -99,8 -147 32.31% | -90,5 -91,0 0.52% |
|
EBIT Million SEK | Released Forecast Spread | -120 -95,0 -26.46% | 0,00 | -129 -176 26.95% | -165 -164 -0.61% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -138 -113 -22.29% | 0,00 | -133 -179 25.85% | -167 -167 0.19% |
|
Net income Million SEK | Released Forecast Spread | -171 -146 -17.36% | -10,5 | -133 -179 25.85% | -167 -167 0.19% |
|
EPS SEK | Released Forecast Spread | -0,88 -0,58 -51.39% | -0,03 | -0,30 -0,40 25% | -0,34 -0,31 -9.68% |
| Announcement Date | 28/06/19 | 19/08/20 | 24/02/22 | 23/02/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 |
|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 9,64 0,20 4719.5% |
|
EBITDA Million SEK | Released Forecast Spread | 5,21 -33,9 115.36% |
|
EBIT Million SEK | Released Forecast Spread | -2,07 -41,1 94.97% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -2,85 -41,8 93.18% |
|
Net income Million SEK | Released Forecast Spread | -2,85 -41,8 93.18% |
| Announcement Date | 24/02/22 |
More events
Past sector events for OASA PHARADR
| Today | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| Today | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 14/05/2024 | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 14/05/2024 22:43 | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 09:52 | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 14/05/2024 06:30 | BAYER AG: Q1 2024 Earnings Release |
